Antirobe 150 mg Capsule, hard
Antirobe 150 mg Capsule, hard
Authorised
- Clindamycin hydrochloride
Product identification
Medicine name:
Antirobe 150 mg Capsule, hard
Antirobe 150 mg Gélule
Antirobe 150 mg Hartkapsel
Active substance:
- Clindamycin hydrochloride
Target species:
-
Cat
-
Dog
Route of administration:
-
Oral use
Product details
Active substance and strength:
-
Clindamycin hydrochloride162.90/milligram(s)1.00Capsule
Pharmaceutical form:
-
Capsule, hard
Withdrawal period by route of administration:
-
Oral use
-
Cat
-
Dog
-
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QJ01FF01
Legal status of supply:
-
Veterinary medicinal product subject to veterinary prescription
Authorisation status:
-
Valid
Authorised in:
-
Belgium
Available in:
-
Belgium
Package description:
- 80 tablets: box with 10 capsules per blister
- 16 tablets: box with 8 capsules per blister
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Full application (Article 12(3) of Directive No 2001/82/EC)
Marketing authorisation holder:
- Zoetis Belgium
Marketing authorisation date:
Manufacturing sites for batch release:
- Fareva Amboise
Responsible authority:
- Federal Agency For Medicines And Health Products
Authorisation number:
- BE-V155075
Date of authorisation status change:
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
Documents
Summary of Product Characteristics
This document does not exist in this language (English). You can find it
in another language below.
Package Leaflet
This document does not exist in this language (English). You can find it
in another language below.
Labelling
This document does not exist in this language (English). You can find it
in another language below.
How useful was this page?:
